- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lymphoma, Large-Cell, Diffuse in Canada
Total 475 results
-
GenmabAbbVieActive, not recruitingSmall Lymphocytic Lymphoma (SLL) | DLBCL | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | MCL | Marginal Zone Lymphoma (MZL) | High-grade B-cell Lymphoma (HGBCL) | FLKorea, Republic of, United States, Australia, Singapore, Netherlands, Sweden, France, Finland, United Kingdom, Spain, Germany, Denmark, Italy, Poland, Canada
-
Kite, A Gilead CompanyRecruitingHigh-risk Large B-cell Lymphoma (LBCL)United States, Austria, Spain, Italy, Australia, Germany, Netherlands, Canada, Portugal, United Kingdom, France
-
National Cancer Institute (NCI)RecruitingPrimary Mediastinal Large B-Cell LymphomaUnited States, Canada, Australia, Puerto Rico
-
CelgeneNot yet recruitingLarge B-cell LymphomaUnited States, Canada, Argentina, Australia, Austria, Brazil, Bulgaria, Chile, China, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, Japan, Korea, Republic of, Malaysia, Mexico, New Zealand, Norway, Poland, Portug... and more
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
University Health Network, TorontoTakara Bio Inc.RecruitingRelapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma | Relapsed or Refractory CD19+ B-cell LymphomaCanada
-
McGill UniversityUnknownCutaneous T-Cell LymphomaCanada
-
Aegera TherapeuticsThe Leukemia and Lymphoma SocietyTerminatedLymphoma, B-Cell | Leukemia, Lymphocytic, Chronic, B-CellCanada, United States
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupUnknownB-cell Non Hodgkin Lymphoma | Mature B-cell Leukemia Burkitt-typeBelgium, France, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain, China
-
Hebei Senlang Biotechnology Inc., Ltd.CompletedT-cell Acute Lymphoblastic Leukemia/LymphomaChina
-
AHS Cancer Control AlbertaNot yet recruiting
-
Daiichi SankyoActive, not recruitingRelapsed/Refractory Peripheral T-Cell Lymphoma | Adult T Cell Leukemia/LymphomaUnited States, Spain, Japan, United Kingdom, Korea, Republic of, France, Italy, Australia, Canada, Germany, Netherlands, Taiwan
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizerCompletedLymphoblastic Lymphoma | Peripheral T-cell Lymphoma | Lymphoblastic Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
National Cancer Institute (NCI)TerminatedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Recurrent Childhood Acute Lymphoblastic Leukemia | T-cell Large Granular Lymphocyte Leukemia | T-cell Childhood Acute Lymphoblastic... and other conditionsUnited States, Canada
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); ShireActive, not recruitingAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States, Canada
-
MedImmune LLCNational Cancer Institute (NCI)CompletedNon-Hodgkin's Lymphoma | Acute Lymphoblastic LeukemiaUnited States, Canada
-
University of AlbertaAlberta Cancer Foundation; Canadian Cancer Trials GroupRecruitingRelapsed Non Hodgkin Lymphoma | Relapsed Pediatric ALL | Relapsed Adult ALLCanada
-
Pacylex PharmaceuticalsOzmosis Research Inc.RecruitingAdvanced Solid Tumor | B-cell Non Hodgkin LymphomaCanada
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Czechia, Sweden, Germany, Belgium, Italy, Canada, France, Netherlands, Poland
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
University Health Network, TorontoTerminatedLymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | MyelodysplasiaCanada
-
Eleah StringerBC Cancer FoundationCompletedNeoplasms | Inflammation | Lymphoma, Small Lymphocytic | Diet Habit | Intermittent Fasting | Leukemia, Lymphocytic, ChronicCanada
-
Prelude TherapeuticsBeiGeneRecruitingT-cell Lymphoma | Mantle Cell Lymphoma (MCL) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Syndrome | Aggressive B-Cell Non-Hodgkin's Lymphoma | Aggressive B-Cell NHLUnited States, Canada, Korea, Republic of, Australia, France, Poland, Italy, Germany, Switzerland, United Kingdom
-
Rigel PharmaceuticalsCompletedT Cell LymphomaUnited States, Canada
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinCanada, Spain, United States, Austria
-
NCIC Clinical Trials GroupCompleted
-
S*BIOCompletedHodgkin Lymphoma | Mantle Cell Lymphoma | Indolent LymphomaUnited States, Canada
-
Canadian Cancer Trials GroupAbbVie; Roche Pharma AG; Incyte CorporationRecruiting
-
University Health Network, TorontoActive, not recruiting
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedMantle Cell LymphomaCanada
-
Therapeutic Advances in Childhood Leukemia ConsortiumGlaxoSmithKline; NovartisTerminatedRelapsed T-Cell Acute Lymphoblastic Leukemia | Relapsed T-Cell Lymphoblastic LymphomaUnited States, France, Canada, Australia, Austria, Italy, Netherlands
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaCanada
-
British Columbia Cancer AgencyUniversity of Victoria; BC Cancer FoundationCompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)Canada
-
Ontario Clinical Oncology Group (OCOG)Hoffmann-La RocheCompletedHIV Infections | Lymphoma, AIDS RelatedCanada
-
PETHEMA FoundationGrupo Español de Linfomas y Transplante Autólogo de Médula ÓseaRecruitingMature B-Cell Leukemia Burkitt Type | Burkitt Lymphoma (BL) | Unclassifiable Lymphoma Between DCBL and BLSpain
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States, Canada
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaCanada
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
Jazz PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States, Canada
-
Stephen CoubanGenzyme, a Sanofi CompanyCompletedMalignant Lymphoma, Stem Cell TypeCanada
-
Canadian Immunization Research NetworkCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous... and other conditionsUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic Leukemia | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Childhood Lymphoblastic Lymphoma | Childhood T Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada
-
Merck Sharp & Dohme LLCRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Richter Transformation LymphomaPoland, United States, Canada, Chile, China, Estonia, Israel, Italy, Korea, Republic of, Spain, Sweden, Turkey, Czechia, Germany, Brazil, Portugal, Ireland, Singapore, United Kingdom, Japan, Peru
-
Ottawa Hospital Research InstituteRecruitingNon-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaCanada
-
NCIC Clinical Trials GroupCompleted
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkin Lymphoma | B-Cell LymphomaUnited States, Italy, Canada, Australia, Spain, Denmark, France, Germany, United Kingdom
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark